Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33644 | 88 | 25.4 | 45% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 311 | 17667 | HEALTH POLICY & SERVICES//HEALTH AFFAIRS//INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CARDIOVASC METABOL SERV | Address | 1 | 100% | 2% | 2 |
| 2 | FORMULARY DEV | Address | 1 | 50% | 2% | 2 |
| 3 | SPECIALTY DRUGS | Author keyword | 1 | 100% | 2% | 2 |
| 4 | US HLTH SERV | Address | 1 | 50% | 2% | 2 |
| 5 | HLTH CARE CONSULTING FIRM | Address | 1 | 50% | 1% | 1 |
| 6 | CORP ACCOUNTS | Address | 0 | 33% | 1% | 1 |
| 7 | HOUSEHOLD BURDEN | Author keyword | 0 | 33% | 1% | 1 |
| 8 | INTERNATIONAL EXHAUSTION | Author keyword | 0 | 33% | 1% | 1 |
| 9 | SPECIALTY PHARMACY | Author keyword | 0 | 33% | 1% | 1 |
| 10 | P4P | Author keyword | 0 | 14% | 2% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SPECIALTY DRUGS | 1 | 100% | 2% | 2 | Search SPECIALTY+DRUGS | Search SPECIALTY+DRUGS |
| 2 | HOUSEHOLD BURDEN | 0 | 33% | 1% | 1 | Search HOUSEHOLD+BURDEN | Search HOUSEHOLD+BURDEN |
| 3 | INTERNATIONAL EXHAUSTION | 0 | 33% | 1% | 1 | Search INTERNATIONAL+EXHAUSTION | Search INTERNATIONAL+EXHAUSTION |
| 4 | SPECIALTY PHARMACY | 0 | 33% | 1% | 1 | Search SPECIALTY+PHARMACY | Search SPECIALTY+PHARMACY |
| 5 | P4P | 0 | 14% | 2% | 2 | Search P4P | Search P4P |
| 6 | DELPHI TECHNIQUES | 0 | 25% | 1% | 1 | Search DELPHI+TECHNIQUES | Search DELPHI+TECHNIQUES |
| 7 | MEDICARE COVERAGE | 0 | 20% | 1% | 1 | Search MEDICARE+COVERAGE | Search MEDICARE+COVERAGE |
| 8 | MEDICARE REFORM | 0 | 20% | 1% | 1 | Search MEDICARE+REFORM | Search MEDICARE+REFORM |
| 9 | SUPPLEMENTAL INSURANCE | 0 | 20% | 1% | 1 | Search SUPPLEMENTAL+INSURANCE | Search SUPPLEMENTAL+INSURANCE |
| 10 | COMPULSORY LICENSE | 0 | 17% | 1% | 1 | Search COMPULSORY+LICENSE | Search COMPULSORY+LICENSE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BENEFIT DESIGN | 1 | 23% | 3% | 3 |
| 2 | MEDICARE MODERNIZATION ACT | 1 | 50% | 1% | 1 |
| 3 | CORE DIABETES MODEL | 0 | 25% | 1% | 1 |
| 4 | SPENDING PROJECTIONS | 0 | 25% | 1% | 1 |
| 5 | FUTURE DRUG EXPENDITURES | 0 | 14% | 1% | 1 |
| 6 | MODERNIZATION ACT | 0 | 13% | 1% | 1 |
| 7 | SPECIALTY PHARMACEUTICALS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| A Review of Approaches for the Management of Specialty Pharmaceuticals in the United States | 2014 | 1 | 11 | 36% |
| An analysis of FDA-approved drugs for oncology | 2014 | 2 | 12 | 8% |
| Cost of cancer clinical trials in elderly patients | 2004 | 2 | 38 | 3% |
| The management of hypertension for primary stroke prevention: a proposed approach | 2011 | 4 | 50 | 2% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CARDIOVASC METABOL SERV | 1 | 100% | 2.3% | 2 |
| 2 | FORMULARY DEV | 1 | 50% | 2.3% | 2 |
| 3 | US HLTH SERV | 1 | 50% | 2.3% | 2 |
| 4 | HLTH CARE CONSULTING FIRM | 1 | 50% | 1.1% | 1 |
| 5 | CORP ACCOUNTS | 0 | 33% | 1.1% | 1 |
| 6 | GASTROINTESTINAL BIOL DIS MED | 0 | 25% | 1.1% | 1 |
| 7 | HPHC | 0 | 25% | 1.1% | 1 |
| 8 | MAYES HEALTHCARE BUSINESS POLICY | 0 | 25% | 1.1% | 1 |
| 9 | GOVT RELAT | 0 | 20% | 1.1% | 1 |
| 10 | REG STROKE PROGRAM | 0 | 20% | 1.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000268281 | HLTH SERV ECON BRANCH//FINANCIAL TOXICITY//OUT OF POCKET COSTS |
| 2 | 0.0000245961 | MEDICARE PART D//PRIOR AUTHORIZATION//CO PAYMENT |
| 3 | 0.0000160648 | ACCOUNTABLE CARE ORGANIZATIONS//BUNDLED PAYMENTS//PRIVATE MARKET INNOVAT |
| 4 | 0.0000143458 | DRUG SHORTAGES//VACCINE STOCKPILES//VACCINE SHORTAGE |
| 5 | 0.0000140175 | FLEXIBLE SPENDING ACCOUNTS//MEDICAL SAVINGS ACCOUNTS//HEALTH SAVINGS ACCOUNTS |
| 6 | 0.0000120825 | R ID LEARNING PROJECT//PATIENT AND FAMILY SATISFACTION//FOOD BELIEFS AND PRACTICES |
| 7 | 0.0000114758 | BIOSIMILARS//BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES |
| 8 | 0.0000108279 | GENERIC SUBSTITUTION//GENERIC DRUGS//REFERENCE PRICING |
| 9 | 0.0000107880 | ORAL CHEMOTHERAPY//ORAL ANTICANCER AGENTS//ORAL ANTICANCER DRUGS |
| 10 | 0.0000106608 | HEALTH TECHNOLOGY ASSESSMENT//INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE//COVERAGE WITH EVIDENCE DEVELOPMENT |